Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 – New England Journal of Medicine Editorial: Surviving Covid-19 with Heparin? Commentaries: Full-dose blood thinners reduce the need for organ support in moderately ill COVID-19 patients, but not in critically ill patients – National Institutes of Health Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t […]

The post RCT: In noncritically ill patients hospitalized with Covid-19, therapeutic-dose anticoagulation with heparin increased the probability of survival to hospital discharge compared with usual-care thromboprophylaxis. appeared first on Links Medicus.